Breaking Finance News

Zacks Investment Research upgraded Fabrinet (NYSE:FN) to Hold in a report released today.

Zacks Investment Research has upgraded Fabrinet (NYSE:FN) to Hold in a report released on 10/17/2016.

Yesterday Fabrinet (NYSE:FN) traded 0.73% higher at $41.30. The company’s 50-day moving average is $42.64 and its 200-day moving average is $37.46. The last stock close price is up 11.04% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 226,008 shares of the stock were exchanged, down from an average trading volume of 544,277

See Chart Below

Fabrinet (NYSE:FN)

Fabrinet has a 52 week low of $20.62 and a 52 week high of $46.50 with a P/E ratio of 24.76 The company’s market cap is currently $0.

In addition to Zacks Investment Research reporting its target price, a total of 6 firms have reported on the stock. The consensus target price is $34.17 with 1 firm rating the stock a strong buy, 5 firms rating the stock a buy, 0 firms rating the stock a hold, 0 firms rating the stock a underperform, and finally 0 firms rating the stock a sell.

About Fabrinet (NYSE:FN)

Fabrinet provides optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers (OEMs) of products, such as optical communication components, modules and sub-systems, industrial lasers, medical devices and sensors. The Company offers a range of optical and electro-mechanical capabilities across the manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advanced packaging, integration, final assembly and test. The Company's customer base includes companies in industries that require precision manufacturing capabilities, such as optical communications, industrial lasers, automotive, medical and sensors. Its customers in these industries support end-markets, including automotive, biotechnology, communications, materials processing, medical devices, metrology and semiconductor processing.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.